1.85
price down icon6.57%   -0.13
after-market Dopo l'orario di chiusura: 1.85
loading
Precedente Chiudi:
$1.98
Aprire:
$1.98
Volume 24 ore:
138.02K
Relative Volume:
0.57
Capitalizzazione di mercato:
$137.53M
Reddito:
-
Utile/perdita netta:
$-19.57M
Rapporto P/E:
-0.5911
EPS:
-3.13
Flusso di cassa netto:
$-17.24M
1 W Prestazione:
-2.63%
1M Prestazione:
+11.45%
6M Prestazione:
-34.16%
1 anno Prestazione:
+12.80%
Intervallo 1D:
Value
$1.80
$1.99
Intervallo di 1 settimana:
Value
$1.80
$1.995
Portata 52W:
Value
$1.12
$4.20

Inhibikase Therapeutics Inc Stock (IKT) Company Profile

Name
Nome
Inhibikase Therapeutics Inc
Name
Telefono
678-392-3419
Name
Indirizzo
3350 RIVERWOOD PARKWAY SE, SUITE 1900, ATLANTA
Name
Dipendente
16
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
IKT's Discussions on Twitter

Confronta IKT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IKT
Inhibikase Therapeutics Inc
1.85 147.20M 0 -19.57M -17.24M -3.13
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Inhibikase Therapeutics Inc Stock (IKT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-12 Downgrade H.C. Wainwright Buy → Neutral

Inhibikase Therapeutics Inc Borsa (IKT) Ultime notizie

pulisher
Jul 24, 2025

What drives Inhibikase Therapeutics Inc. stock priceConsistently high yield - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

How high can Inhibikase Therapeutics Inc. stock price go in 2025Rapid profit acceleration - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Inhibikase Therapeutics Inc. Stock Analysis and ForecastUnrivaled growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Inhibikase Therapeutics Inc. a good long term investmentPhenomenal investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Inhibikase Therapeutics Inc. stockBreakout profit opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Tianci International Inc. stockTriple-digit profit margins - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

How Inhibikase Therapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Inhibikase Therapeutics Inc. stock price move sharplyVolume Spike Monitors - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

What risks could impact Inhibikase Therapeutics Inc. stock performance2x Return Forecast - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Why Inhibikase Therapeutics Inc. stock attracts strong analyst attentionSmart High Yield Swing Trades - beatles.ru

Jul 17, 2025
pulisher
Jul 01, 2025

Inhibikase Therapeutics Approves Key Proposals at Annual Meeting - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

Inhibikase Therapeutics shareholders elect directors and approve equity plan changes - Investing.com India

Jun 30, 2025
pulisher
Jun 30, 2025

Inhibikase Therapeutics Soars 6.79% on Russell 2000 Index Addition - AInvest

Jun 30, 2025
pulisher
Jun 29, 2025

Inhibikase Therapeutics, Inc.(NasdaqCM: IKT) added to Russell 2500 Index - MarketScreener

Jun 29, 2025
pulisher
Jun 28, 2025

IKT SEC FilingsInhibikase Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 25, 2025

Ludwig Enterprises appoints Garth Lees-Rolfe as independent director By Investing.com - Investing.com UK

Jun 25, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Acquires Shares of 28,411 Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Invests $462,000 in Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Jun 10, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Invests $208,000 in Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Jun 03, 2025
pulisher
May 27, 2025

Inhibikase Therapeutics Insider Buyers Pleased With US$788k Return On Investment - simplywall.st

May 27, 2025
pulisher
May 23, 2025

Inhibikase Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 23, 2025
pulisher
May 17, 2025

13,129 Shares in Inhibikase Therapeutics, Inc. (NYSE:IKT) Purchased by Stifel Financial Corp - Defense World

May 17, 2025
pulisher
May 16, 2025

Inhibikase Therapeutics: Strategic Realignment and Financial Strength Justify Buy Rating - TipRanks

May 16, 2025
pulisher
May 14, 2025

Inhibikase Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025

Inhibikase Therapeutics Inc Azioni (IKT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):